|
?:authorAffiliation
|
-
[\'Center for Infectious Disease Modeling and Analysis (CIDMA), Yale School of Public Health, New Haven, CT, 06520, USA.\', \'Department of Biostatistics, Yale School of Public Health, New Haven, CT, 06510, USA. Jeffrey.Townsend@Yale.edu.\', \'Department of Ecology and Evolutionary Biology, Yale University, New Haven, CT, 06525, USA. Jeffrey.Townsend@Yale.edu.\', \'Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT, 06511, USA. Jeffrey.Townsend@Yale.edu.\', \'Program in Microbiology, Yale University, New Haven, CT, 06511, USA. Jeffrey.Townsend@Yale.edu.\', \'Agent-Based Modelling Laboratory, York University, Toronto, ON, M3J 1P3, Canada.\', \'NewFields E&E, Boulder, CO, 80301, USA.\', \'Skaggs School of Pharmacy and Pharmaceutical Science, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.\', \'Emerging Pathogens Institute, University of Florida, P.O. Box 100009, Gainesville, FL, 32610, USA.\', \'Group Health, Safety and Environment; BHP, Melbourne, VIC, 3000, Australia.\', \'Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MA, 21201, US.\', \'Department of Ecology and Evolutionary Biology, Yale University, New Haven, CT, 06525, USA.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}